Coat-X

Coat-X specializes in advanced parylene barrier coatings and deposition systems, effectively protecting sensitive printed circuit board assemblies and components in demanding environments, particularly in the medical technology and electronics sectors. Coat-X is a company focused on providing parylene coatings for PCBAs and components. Founded in 2016, in La Chaux-de-Fonds, Switzerland, the company has engaged in one notable deal as of November 21, 2018. CEO Andreas Hogg leads the company.

COAT-X SA specializes in advanced parylene barrier coatings and deposition systems, providing essential protection for sensitive printed circuit board assemblies (PCBAs) and components utilized in challenging environments. Their core offerings include parylene thin films, branded as CX PROTECT, available in types such as N, C, VT, and AF4, along with multilayer composites like CX ULTRA and CX ULTIMA. These solutions significantly reduce water permeability and are vital for applications in active implantable medical devices and electronic circuits in hostile conditions. COAT-X serves a diverse clientele in the medical technology sector, notably manufacturers of implantable electronics and wearables, as well as the broader electronics market, including flexible and rigid PCBs and sensors.

The company operates predominantly in Europe and North America, catering to customers requiring high production capacity and specialized coating solutions. COAT-X generates revenue through job coating services and the sale of automated deposition systems for chemical vapor deposition (CVD), plasma-enhanced CVD (PE-CVD), and atomic layer deposition (ALD) processes. Their revenue model includes direct sales to businesses in the medical device and electronics manufacturing sectors, along with potential partnerships for ongoing coating services. The company offers its systems in three standard sizes—30L, 300L, and 600L—all customizable to meet specific client requirements.

Given the specialized nature of their products, pricing structures are determined by factors such as coating complexity and production scale, ensuring tailored solutions for customers. Flagship products, including CX PROTECT and multilayer composites, are significant components of their revenue stream, particularly in high-demand markets like AIMD. Coat-X is strategizing for growth by designing new products and expanding into new markets. The recent Series B funding raised in November 2018 will support these initiatives.

Future product launches are anticipated, and specific targets for market expansion are in place, focusing on increasing presence in both the medical technology and electronics sectors. The company aims to leverage its recent funding to enhance its product offerings and expand operational capabilities.